Antiphospholipid antibodies and coronary arterial thrombosis

Cardiovascular Reviews and Reports

Volumn 20, Issue 6, 1999, Pages

  Sullivan, Margaret A ^a   DePasquale, Nicholas P ^a   Coplan, Neil L ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY TITER; ANTICOAGULATION; AUTOIMMUNE DISEASE; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; FETUS WASTAGE; HUMAN; REVIEW; RISK BENEFIT ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 6544291027     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis, 1985;11:591-609.
2. Mackworth-Young CJ, Loizou S, Walport MJ. Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis. 1989;48:362-367.
3. Asherson RA, Baguley E, Pal C, et al. Antiphospholipid syndrome: Five year follow up. Ann Rheum Dis. 1991; 50:805-810.
4. Hughes GRV. The antiphospholipid syndrome: Ten years on. Lancet. 1993;342:341-344.
5. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol. 1989;16:482-488.
6. Asherson RA, Khamashta MA, Ori-Ross J, et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine. 1989;68:366-374.
7. Hughes GRV. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. BMJ. 1983;287:108-189.
8. Harris EN, Gharavi AE, Boye ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2: 1211-1214.
9. Boey ML, Colaco CB, Gharavi AE, et al. Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating lupus anticoagulant. BMJ. 1983;287:1021-1023.
10. Lockshin MD. Lupus and antiphospholipd antibody syndrome: Either, neither, or both. Am J Med. 1994;96:1-2.
11. Piette JC, Cacoub P. Antiphospholipid syndrome in the elderly: Caution. Circulation. 1998;97:2195-2196.
12. Vianna JL, Khamashta MA, Ordii-Ross J, et al. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med. 1994;96:3-9.
13. Triplett DA. Antiphospholipid antibodies and thrombosis. Arch Path Lab Med. 1993;117:78-88.
14. Krnic-Barrie S, O'Connor CR, Looney SW, et al. A retrospective review of 61 patients with antiphospholipid syndrome. Arch Intern Med. 1997;157:2101-2108.
15. Hamsten A, Bjorkholm M, Norberg R. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet. 1986;1:113-116.
16. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Circulation. 1991;84:920-923.
17. Kaplan SD, Chartash EK, Pizzarello RA, et al. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J. 1992;124:1331-1338.
18. Hojnik M, George J, Ziporen L, et al. Heart valve involvement (Libman-Sacks Endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-1587.
19. Brenner B, Blumenfeld Z, Markiewicz W, et al. Cardiac involvement in patients with primary antiphospholipid syndrome. J. Am Coll Cardiol. 1991;18:931-936.
20. Skyrme-Jones RA, Wardrop CA, Wiles CM, et al. Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with the primary antiphospholipid syndrome. J Am Soc Echocardiogr. 1995;8:251-256.
21. Agirbasli MA, Hansen DE, Byrd BF. Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome. J Am Soc Echocardiogr. 1997;10:877-880.
22. Asherson RA, Khamashta MA, Baguley E, et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med. 1989;73:1103-1115.
23. Vaarala O, Manttari M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 1995;91:23-27.
24. De Caterina R, d'Ascanio A, Mazzone A, et al. Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol. 1990;65:922-923.
25. Phadke KV, Phillips RA, Clarke, DTR, et al. Anticardiolipin antibodies in ischaemic heart disease: Marker or myth? Br Heart J. 1993;69:391-394.
26. Sletnes KE, Smith P, Abdelnoor M, et. al. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-hemorrhagic stroke. Lancet. 1992;339:451-453.
27. Raghavan C, Ditchfield J, Taylor RJ, et al. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol. 1993; 46:1113-1115.
28. Diaz MN, Becker RC. Anticardiolipin antibodies in patients with unstable angina. Cardiology. 1994;84:380-384.
29. Morton KE, Gavaghan TP, Krillis SA, et al. Coronary artery bypass graft failure-an autoimmune phenomenon? Lancet. 1986;2:1353-57.
30. Anglin P, Strauss BH, Brandwein JM, et al. Lupus anticoagulant: A potential risk factor for complication following percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diag. 1994;31:130-132.
31. Chambers JD, Haire WD, Deligonul U Multiple early percutaneous transluminal coronary angioplasty failures related to lupus anticoagulant. Am Heart J. 1996;132:189-190.
32. Ahn SS, Kalunian K, Rosove M, et al. Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures. J Vasc Surg. 1988;7:749-756.
33. Harpaz D, Glikson M, Sidi Y, et al. Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome. Am Heart J. 1991; 122:1492-1494.
34. Ho YL, Chen MF, Wu CC, et al. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Cardiology. 1996;87:354-357.
35. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992;117:303-308.
36. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med. 1995;332:993-997.
37. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med. 1997;127:177-185.